The lifecycle of a containment installation does not end when it goes into operation - it is only just beginning
The handling of extremely potent active ingredients is on the rise in contemporary pharmaceutical production facilities. Production environments thus have to be adapted to protect the Personnel, product and the environment all at the same time, while adhering with GMP guidelines.
OEL Specific Systems
Our team has accrued wide-ranging expertise in planning and implementing containment projects. Developing containment solutions for different products and dosage forms is as much a part of our daily business as optimising concepts for processing highly active ingredients according to their Operator Exposure Limits (OELs). We are specialised in solids production and liquid pharmaceutical filling alike as also with Formulations and API containment plants – from concept design to implementation and qualification.
Please write to us to converse about containment solutions tailored to your specific requirements. If you are new to the field of containment and want to possibly have an investment in the near future. Our team can advice and hand hold with technology transfers and guide you through the process.
Existing Facility Upgrade
If you already have a containment facility, we can help with optimising your containment processes according to the respective OEL levels for:
- Existing Process Machinery in Isolators – Restricted Access Barrier systems
- Personnel protection measures
- Airlock and pressure cascades
- Material Flow methodology
- Decontamination measures
Critical Gap Analysis
If you have general facility and equipments and want to convert in potent (onco, hormone, other potent) products then we will help you with gap analysis and customized containment system with your existing equipment.
We consider the opinions for and against open and closed containment systems, and analyse the potential of multi utility Isolators versus dedicated Equipment for Specific operations.